Cyclooctadepsipeptides–an anthelmintically active class of compounds exhibiting a novel mode of action.
Abstract: There are three major classes of anthelmintics for veterinary use: the benzimidazoles/prebenzimidazoles, the tetrahydropyrimidines/imidazothiazoles, and the macrocyclic lactones. In nematodes, there are five targets for the existing anthelmintics: the nicotinergic acetylcholine receptor which is the target of tetrahydropyrimidines/imidazothiazoles and indirectly that of the acetylcholineesterase inhibitors; the GABA receptor which is the target of piperazine, the glutamate-gated chloride channel as the target of the macrocyclic lactones, and beta-tubulin as the target of prebenzimidazoles/benzimidazoles. All these anthelmintics are now in serious danger because of the worldwide spread of resistant nematodes in sheep, cattle, horses and pigs. The class of cyclooctadepsipeptides has entered the scene of anthelmintic research in the early 1990s. PF1022A, the first anthelmintically active member, is a natural compound from the fungus Mycelia sterilia that belongs to the microflora of the leaves of the Camellia japonica. PF1022A contains 4 N-Methyl-L-leucines, 2 D-lactic acids and 2-D-phenyllactic acids arranged as a cyclic octadepsipeptide with an alternating L-D-L-configuration. Emodepside is a semisynthetic derivative of PF1022A with a morpholine ring at each of the two D-phenyllactic acids in para position. The anthelmintic activity is directed against gastrointestinal nematodes in chicken, mice, rats, meriones, dogs, cats, sheep, cattle and horses. Moreover, emodepside is active against Trichinella spiralis larvae in muscles, microfilariae and preadult filariae and Dictyocaulus viviparus. PF1022A and emodepside are fully effective against benzimidazole-, levamisole or ivermectin-resistant nematodes in sheep and cattle. In Ascaris suum both cyclooctadepsipeptides lead to paralysis indicating a neuropharmacological action of these compounds. Using a PF1022A-ligand immunoscreening of a cDNA library from Haemonchus contortus a cDNA clone of 3569 base pairs could be identified. This clone codes for a novel 110 kDa heptahelical transmembrane receptor, named HC110R. Database- and phylogenetic analysis reveals that this receptor is a homolog to B0457.1 from Caenorhabditis elegans and has significant similarity to latrophilins from human, cattle and rat. HC110R is located in the plasma membrane and in lysosomes and endosomes. Alpha-latrotoxin, the poison of the black widow spider, binds at a 54 kDa aminoterminal fragment of HC110R. After binding a Ca2+-influx into HEK293 cells is induced which can be blocked by EGTA, Cd2+ or nifedipin. PF1022A or emodepside also bind to this 54 kDa aminoterminal region of HC110R and interact with the functional responses of alpha-latrotoxin. In C. elegans antibodies against the C-or N-terminus of HC110R bind to the B0457.1 protein located in the pharynx. Electrophysiological studies reveal that emodepside inhibits pharyngeal pumping of the nematodes in a concentration dependent way with an IC(50) value of about 4 nM. Thus, it is tempting to speculate that emodepside exerts its action on nematodes via a latrophilin-like receptor which might have an important regulatory function on pharyngeal pumping.
Publication Date: 2003-09-19 PubMed ID: 13678839DOI: 10.1016/s0924-8579(03)00219-xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
- Review
- Anthelmintic Resistance
- Anthelmintic Treatment
- Biochemistry
- Disease Management
- Disease Treatment
- Drug
- Equine Diseases
- Equine Health
- Genetics
- In Vitro Research
- In Vivo
- Laboratory Methods
- Molecular biology
- Nematodes
- Pharmacodynamics
- Pharmacokinetics
- Pharmacology
- Veterinary Medicine
- Veterinary Research
- Veterinary Science
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This research paper explores how a group of compounds, called cyclooctadepsipeptides, can be used as alternative anthelmintics (worm medicines) for animals, due to their different mode of action which overcomes the issue of resistance in many gut worms to traditional drugs.
Introduction and Background
- The study focuses on cyclooctadepsipeptides, a class of compounds that have shown anthelmintic (worm-killing) activity, and propose a novel mode of action against parasites.
- The research comes as the effectiveness of the three main anthelmintics in use (benzimidazoles/prebenzimidazoles, tetrahydropyrimidines/imidazothiazoles, and macrocyclic lactones) is threatened by the global spread of resistance in nematodes infecting various farm animals and pets.
Research on Cyclooctadepsipeptides
- Cyclooctadepsipeptides became a focus of anthelmintic research in the early 90s, with PF1022A, a natural compound derived from the fungus Mycelia sterilia, found on Camellia japonica leaves, being the first to demonstrate such activity.
- Emodepside, a semi-synthetic derivative of PF1022A, showed effectiveness against several types of gastrointestinal nematodes found in a range of animals, from poultry to horses, and also against certain forms of filarial worms and lungworms.
- Both PF1022A and emodepside were found effective against nematodes resistant to the main classes of anthelmintics.
Mode of Action
- In a test with Ascaris suum (a species of parasitic roundworm), both types of cyclooctadepsipeptides caused paralysis, suggesting a neuropharmacological effect.
- A cDNA (complementary DNA) clone, coding for a novel 110 kDa heptahelical transmembrane receptor (named HC110R), was identified from a PF1022A-ligand immunoscreen of a cDNA library from Haemonchus contortus (a species of parasitic worm).
- HC110R was found to be similar to latrophilins (receptors that bind alpha-latrotoxin, the poison from the Black widow spider) and had significant similarity to those found in humans, cattle, and rats.
- Emodepside and PF1022A were found to bind to the same receptor fragment that alpha-latrotoxin binds to, interacting with its functional responses.
- In the nematode Caenorhabditis elegans, antibodies against the C-or N-terminus of HC110R was shown to bind to the B0457.1 protein located in the pharynx.
- Emodepside inhibited the pharyngeal pumping of the nematodes in a concentration-dependent manner, reinforcing the theory that it acts via a latrophilin-like receptor, which may regulate this activity in nematodes.
Cite This Article
APA
Harder A, Schmitt-Wrede HP, Krücken J, Marinovski P, Wunderlich F, Willson J, Amliwala K, Holden-Dye L, Walker R.
(2003).
Cyclooctadepsipeptides–an anthelmintically active class of compounds exhibiting a novel mode of action.
Int J Antimicrob Agents, 22(3), 318-331.
https://doi.org/10.1016/s0924-8579(03)00219-x Publication
Researcher Affiliations
- Bayer AG, BHC, AH-RD-Para, Alfred-Nobel-Strasse 50, D-40789 Manheim, Germany. achim-harder-ah@bayer.ag.de
MeSH Terms
- Animals
- Anthelmintics / chemistry
- Anthelmintics / classification
- Anthelmintics / pharmacology
- Binding Sites
- Depsipeptides
- Drug Resistance
- Helminth Proteins / genetics
- Helminth Proteins / metabolism
- Helminthiasis / drug therapy
- Helminthiasis, Animal / drug therapy
- Helminths / drug effects
- Humans
- Nematoda / drug effects
- Peptides, Cyclic / chemistry
- Peptides, Cyclic / pharmacology
- Phylogeny
Citations
This article has been cited 37 times.Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists